NCT03162133
- Conditions
- Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Guangdong General Hospital Guangzhou, Guangdong, China
Clinical trial condition
Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.
NCT03162133
NCT04002284
NCT02786797
NCT00570323
NCT03375801
NCT00206518
NCT02287675
NCT00054301
NCT00949247
NCT03319342